Medicine and Dentistry
Abdominal Aortic Aneurysm
100%
Arteriosclerosis Obliterans
71%
Cardiovascular System
43%
Vascular Surgery
33%
Screening
28%
Cost-Effectiveness Analysis
26%
Revascularization
25%
Cardiovascular Disease
23%
Blood Pressure
23%
Cohort Analysis
20%
Prevalence
20%
Randomized Controlled Trial
19%
Amputation
18%
Aortic Aneurysm
17%
Surgery
16%
Odds Ratio
16%
Health Care Cost
15%
Maturity Onset Diabetes of the Young
13%
Ischemia
12%
Aneurysm
12%
Quality Adjusted Life Year
11%
Abdominal Aortic Aneurysm Repair
11%
Thrombus
11%
Toe
11%
e-Health
11%
Disease
11%
Endovascular Aneurysm Repair
10%
Arm
10%
Hemodynamic
9%
Population
9%
Health Literacy
9%
Ankle Brachial Index
9%
Antiplatelet
9%
Atherosclerosis
9%
Bleeding
8%
All Cause Mortality
8%
C Reactive Protein
8%
Bypass Surgery
8%
Myocardial Infarction
8%
Quality of Life
8%
Hazard Ratio
8%
Cross Sectional Study
7%
Vascular Disease
7%
Apoplexy
7%
Systolic Blood Pressure
7%
Statin
7%
Limb
7%
Awareness
7%
Drug Therapy
7%
Mass Screening
6%
Low Drug Dose
6%
Acetylsalicylic Acid
6%
Aortic Rupture
6%
Surgeon
6%
Case-Control Study
6%
Intermittent Claudication
6%
Meta-Analysis
5%
Angiotensin II
5%
Cardioplegia
5%
Counseling
5%
Endoleak
5%
Magnetic Resonance Imaging
5%
Aquaporin 1
5%
Erysipelas
5%
Palpation
5%
Intermittent Pneumatic Compression
5%
Critical Limb Ischemia
5%
Acute Aortic Syndrome
5%
Blood Flow
5%
Osteocalcin
5%
Attributable Risk
5%
Vitamin K2
5%
Pulse Rate
5%
Telemedicine
5%
Angiotensin
5%
Coronary Computed Tomography Angiography
5%
Neck
5%
Supplementation
5%
Diabetic Foot Ulcer
5%
Glutamic Acid
5%
Predictive Factor
5%
Cardiovascular Medicine
5%
Blood Vessel Shunt
5%
Atherectomy
5%
Malignant Neoplasm
5%
Isotopes of Calcium
5%
Sigmoidoscopy
5%
Heart Cycle
5%
Heparin
5%
Beta Adrenergic Receptor Blocking Agent
5%
Cardiovascular Condition
5%
Roxithromycin
5%
Renin
5%
Cystatin C
5%
Diabetes
5%
Dose Response
5%
Popliteal Artery
5%
Knee Dislocation
5%
Telerehabilitation
5%
Plethysmography
5%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Aortic Aneurysm
94%
Peripheral Occlusive Artery Disease
51%
Cardiovascular Disease
22%
Disease
21%
Cohort Study
21%
Antiplatelet
19%
Prevalence
19%
Statin (Protein)
13%
Acetylsalicylic Acid
13%
Heart Infarction
12%
Antihypertensive Agent
11%
Comorbidity
11%
Mouse
10%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
All Cause Mortality
9%
Case-Control Study
9%
Cross-Sectional Study
8%
Case Fatality Rate
7%
Atherosclerosis
7%
Anticoagulant Agent
6%
Intermittent Claudication
6%
Aortic Rupture
6%
Randomized Controlled Trial
6%
Aortic Aneurysm
6%
Cystatin C
5%
Chronic Obstructive Lung Disease
5%
Acute Aortic Syndrome
5%
Osteocalcin
5%
Obesity
5%
Non Insulin Dependent Diabetes Mellitus
5%
Farnoquinone
5%
Heart Disease
5%
Symptom
5%
Roxithromycin
5%
Beta Adrenergic Receptor Blocking Agent
5%
Heparin
5%
Malignant Neoplasm
5%
Swallow (Bird)
5%
Angiotensin
5%
Asthma
5%
Renin
5%
Small Clinical Trial
5%
Aquaporin 1
5%
Vascular Lesion
5%
Angiotensin II
5%
Hyperplasia
5%
Ovine Model
5%
Ischemic Heart Disease
5%
Nursing and Health Professions
Abdominal Aortic Aneurysm
57%
Peripheral Occlusive Artery Disease
26%
Prophylaxis
18%
Revascularization
17%
Drug Therapy
16%
Cardiovascular Disease
14%
Screening
14%
Telehealth
11%
Blood Pressure
11%
Thrombus
11%
Cyclorphan
11%
Health Care Personnel
10%
Ankle Brachial Index
9%
Amputation
8%
Odds Ratio
8%
Bypass Surgery
8%
Disease
8%
Confidence Interval
7%
Quality of Life
7%
Hazard Ratio
7%
Biological Marker
7%
Attributable Risk
6%
Prevalence
6%
Cross-Sectional Study
6%
Vascular Surgery
6%
Propensity Score
6%
Surgery
6%
Non Insulin Dependent Diabetes Mellitus
6%
Computed Tomographic Angiography
5%
Clinical Practice
5%
Coronary Artery Calcium Score
5%
Telephone Counseling
5%
Telemedicine
5%
Blood Vessel Shunt
5%
Roxithromycin
5%
Arterial Stiffness
5%
Pulse Rate
5%
Angiotensin
5%
Heart Failure
5%
Blood Flow
5%
Immigrant
5%
Evaluation Study
5%
Beta Adrenergic Receptor Blocking Agent
5%
Blood Patch
5%
Hard-To-Heal
5%
Intermittent Claudication
5%
Clinical Outcome
5%
Palpation
5%
Pill
5%
Renin
5%
Telerehabilitation
5%
Postoperative Complication
5%
Heparin
5%
Nuclear Magnetic Resonance Imaging
5%
Cost Effectiveness Analysis
5%